real-time news and commentary for investors
Thursday, Sep 12
J&J makes yet another recall
- Johnson & Johnson (JNJ) is recalling 5,000 vials of its Risperdal Consta schizophrenia treatment after tests found that one lot of the injected drug was contaminated with alternaria alternata, a common mold.
- There have so far been no reports of patient complications.
- The recall is the latest in a series for J&J, which last week recalled 200,000 bottles of its Motrin Infants Drops formula due to a risk that they contained tiny plastic particles.